The US has millions of the AstraZeneca in surplus because it has been produced here but hasn't been approved here. Other countries that have approved it need those vaccines and it would behoove the US to give those vaccines to the places that can use them now.

The U.S. Is Sitting on Tens of Millions of Vaccine Doses the World Needs

Those tens of millions of doses from AstraZeneca are waiting for trial results, while countries that authorized the vaccine beg to have them.

WASHINGTON — Tens of millions of doses of the coronavirus vaccine made by the British-Swedish company AstraZeneca are sitting idly in American manufacturing facilities, awaiting results from its U.S. clinical trial while countries that have authorized its use beg for access.

The fate of those doses of AstraZeneca’s vaccine is the subject of an intense debate among White House and federal health officials, with some arguing the administration should let them go abroad where they are desperately needed while others are not ready to relinquish them, according to senior administration officials.

AstraZeneca is involved in those conversations.